Photo from archive.org
10 years ago, in February 2007, the Towards a Revolution in COPD Health (TORCH) study was published in the New England Journal of Medicine [1]. While the objective of the study… Click to show full abstract
10 years ago, in February 2007, the Towards a Revolution in COPD Health (TORCH) study was published in the New England Journal of Medicine [1]. While the objective of the study was to demonstrate a survival benefit of inhaled corticosteroids (ICS) in combination with long-acting beta-agonists (LABA) compared to placebo in chronic obstructive pulmonary disease (COPD), arguably the most lasting impact of the study on the field of COPD has been a progressive re-evaluation of the safety of ICS [1]. New research identifies an increased risk of NTM infection in inhaled steroid users http://ow.ly/Sk8130ej5Oa
Journal Title: European Respiratory Journal
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!